AngioDynamics Shares Are Trading Higher After Oppenheimer Upgraded the Stock From Perform to Outperform and Announced a $12 Price Target.
AngioDynamics Shares Are Trading Higher After Oppenheimer Upgraded the Stock From Perform to Outperform and Announced a $12 Price Target.
在奧本海默將股票從表現上調至跑贏大盤並宣佈12美元的目標股價之後，AngioDynamics的股價走高。
AngioDynamics Shares Are Trading Higher After Oppenheimer Upgraded the Stock From Perform to Outperform and Announced a $12 Price Target.
在奧本海默將股票從表現上調至跑贏大盤並宣佈12美元的目標股價之後，AngioDynamics的股價走高。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。